Accelerated vs Conventional rTMS for Treatment-Resistant Depression: Insights from a 5×5 Protocol Study
This content is intended for healthcare professionals and is provided for educational purposes only. Transcranial Magnetic Stimulation (TMS) is an established, FDA-cleared treatment for major depressive disorder, including in patients with treatment-resistant depression. Advances in neuromodulation protocols, such as intermittent theta burst stimulation, have reduced session duration and improved treatment efficiency. Building on this, accelerated […]